Cargando…
1-(Piperidin-3-yl)thymine amides as inhibitors of M. tuberculosis thymidylate kinase
A series of readily accessible 1-(piperidin-3-yl)thymine amides was designed, synthesised and evaluated as Mycobacterium tuberculosis TMPK (MtbTMPK) inhibitors. In line with the modelling results, most inhibitors showed reasonable MtbTMPK inhibitory activity. Compounds 4b and 4i were slightly more p...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920704/ https://www.ncbi.nlm.nih.gov/pubmed/31822127 http://dx.doi.org/10.1080/14756366.2019.1662790 |
_version_ | 1783480993585299456 |
---|---|
author | Jian, Yanlin Risseeuw, Martijn D. P. Froeyen, Mathy Song, Lijun Cappoen, Davie Cos, Paul Munier-Lehmann, Hélène van Calenbergh, Serge |
author_facet | Jian, Yanlin Risseeuw, Martijn D. P. Froeyen, Mathy Song, Lijun Cappoen, Davie Cos, Paul Munier-Lehmann, Hélène van Calenbergh, Serge |
author_sort | Jian, Yanlin |
collection | PubMed |
description | A series of readily accessible 1-(piperidin-3-yl)thymine amides was designed, synthesised and evaluated as Mycobacterium tuberculosis TMPK (MtbTMPK) inhibitors. In line with the modelling results, most inhibitors showed reasonable MtbTMPK inhibitory activity. Compounds 4b and 4i were slightly more potent than the parent compound 3. Moreover, contrary to the latter, amide analogue 4g was active against the avirulent M. tuberculosis H37Ra strain (MIC(50)=35 µM). This finding opens avenues for future modifications. |
format | Online Article Text |
id | pubmed-6920704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-69207042020-01-02 1-(Piperidin-3-yl)thymine amides as inhibitors of M. tuberculosis thymidylate kinase Jian, Yanlin Risseeuw, Martijn D. P. Froeyen, Mathy Song, Lijun Cappoen, Davie Cos, Paul Munier-Lehmann, Hélène van Calenbergh, Serge J Enzyme Inhib Med Chem Research Paper A series of readily accessible 1-(piperidin-3-yl)thymine amides was designed, synthesised and evaluated as Mycobacterium tuberculosis TMPK (MtbTMPK) inhibitors. In line with the modelling results, most inhibitors showed reasonable MtbTMPK inhibitory activity. Compounds 4b and 4i were slightly more potent than the parent compound 3. Moreover, contrary to the latter, amide analogue 4g was active against the avirulent M. tuberculosis H37Ra strain (MIC(50)=35 µM). This finding opens avenues for future modifications. Taylor & Francis 2019-12-11 /pmc/articles/PMC6920704/ /pubmed/31822127 http://dx.doi.org/10.1080/14756366.2019.1662790 Text en © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paper Jian, Yanlin Risseeuw, Martijn D. P. Froeyen, Mathy Song, Lijun Cappoen, Davie Cos, Paul Munier-Lehmann, Hélène van Calenbergh, Serge 1-(Piperidin-3-yl)thymine amides as inhibitors of M. tuberculosis thymidylate kinase |
title | 1-(Piperidin-3-yl)thymine amides as inhibitors of M. tuberculosis thymidylate kinase |
title_full | 1-(Piperidin-3-yl)thymine amides as inhibitors of M. tuberculosis thymidylate kinase |
title_fullStr | 1-(Piperidin-3-yl)thymine amides as inhibitors of M. tuberculosis thymidylate kinase |
title_full_unstemmed | 1-(Piperidin-3-yl)thymine amides as inhibitors of M. tuberculosis thymidylate kinase |
title_short | 1-(Piperidin-3-yl)thymine amides as inhibitors of M. tuberculosis thymidylate kinase |
title_sort | 1-(piperidin-3-yl)thymine amides as inhibitors of m. tuberculosis thymidylate kinase |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920704/ https://www.ncbi.nlm.nih.gov/pubmed/31822127 http://dx.doi.org/10.1080/14756366.2019.1662790 |
work_keys_str_mv | AT jianyanlin 1piperidin3ylthymineamidesasinhibitorsofmtuberculosisthymidylatekinase AT risseeuwmartijndp 1piperidin3ylthymineamidesasinhibitorsofmtuberculosisthymidylatekinase AT froeyenmathy 1piperidin3ylthymineamidesasinhibitorsofmtuberculosisthymidylatekinase AT songlijun 1piperidin3ylthymineamidesasinhibitorsofmtuberculosisthymidylatekinase AT cappoendavie 1piperidin3ylthymineamidesasinhibitorsofmtuberculosisthymidylatekinase AT cospaul 1piperidin3ylthymineamidesasinhibitorsofmtuberculosisthymidylatekinase AT munierlehmannhelene 1piperidin3ylthymineamidesasinhibitorsofmtuberculosisthymidylatekinase AT vancalenberghserge 1piperidin3ylthymineamidesasinhibitorsofmtuberculosisthymidylatekinase |